CSL Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CMXHF research report →
Price Chart
About the company
CSL Limited is a global biopharmaceutical enterprise engaged in the discovery, development, production, marketing, and distribution of a wide array of medicinal and related products. Its operations span key markets including Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company's activities are organized into two primary divisions: CSL Behring and Seqirus.
- CEO
- Gordon Naylor DipCompSc
- IPO
- 2005
- Employees
- 29,000
- HQ
- Melbourne, VIC, AU
Get TickerSpark's AI analysis on CMXHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $57.47B
- P/E
- -23.04
- Fwd P/E
- 19.25
- PEG
- 0.13
- P/S
- 3.71
- P/B
- 3.95
- EV/EBITDA
- 13.37
- Div Yield
- 2.49%
- Gross Margin
- 47.76%
- Op Margin
- 25.57%
- Net Margin
- -16.06%
- ROE
- -15.12%
- ROIC
- 10.00%
Latest fiscal year · YoY change
- Revenue
- $16.03B+3.9%
- Gross Profit
- $7.65B-3.8%
- Op Income
- $4.09B
- Net Income
- $-2,632,919,000-187.7%
- EPS
- $-5.46-188.1%
- OCF Growth
- +0.7%
- FCF Growth
- +15.0%
- 52W High
- $150.82
- 52W Low
- $63.84
- 50D MA
- $85.27
- 200D MA
- $99.11
- Beta
- 0.08
- RSI (14)
- 90
- Avg Volume
- 2.60K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Get the CMXHF Q4 '26 earnings-call summary
Create a free account to generate an AI summary of this call — key takeaways, results & guidance, CEO/CFO commentary, Q&A, and a bull vs bear read. Ready in about a minute, and it'll be live for everyone.
Create free account →Already have an account? Log in
- Free Float
- 100.6%
- Shares Outstanding
- 478.91M
- Float Shares
- 481.75M
Our CMXHF coverage
Recent articles, reports, and earnings notes.
No research on CMXHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CMXHF report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.